Hemorrhagic Disorders

Subtype terms (21)

More specific conditions that are subtypes of Hemorrhagic Disorders in the MeSH hierarchy.

• Afibrinogenemia

  3 drugs (2 approved, 1 experimental)

• Bernard-Soulier Syndrome
• Disseminated Intravascular Coagulation

  12 drugs (10 approved, 2 experimental)

• Factor V Deficiency
• Factor VII Deficiency

  8 drugs (3 approved, 5 experimental)

• Factor X Deficiency

  1 drug approved

• Factor XI Deficiency

  1 drug approved

• Factor XII Deficiency
• Factor XIII Deficiency

  1 drug approved

• Hemophilia A

  104 drugs (53 approved, 51 experimental)

• Hemophilia B

  54 drugs (23 approved, 31 experimental)

• Hemostatic Disorders

  7 drugs (2 approved, 5 experimental)

• Hypoprothrombinemias

  3 drugs approved

• Platelet Storage Pool Deficiency

  6 drugs approved

• Purpura, Thrombocytopenic, Idiopathic

  106 drugs (70 approved, 36 experimental)

• Thrombasthenia

  13 drugs (9 approved, 4 experimental)

• Thrombocythemia, Essential

  75 drugs (45 approved, 30 experimental)

• Vitamin K Deficiency

  5 drugs (3 approved, 2 experimental)

• von Willebrand Diseases

  17 drugs (8 approved, 9 experimental)

• Waterhouse-Friderichsen Syndrome
• Wiskott-Aldrich Syndrome

  34 drugs (26 approved, 8 experimental)

Drugs by status

Organizations